Importance of hyperglycemia in COVID-19 intensive-care patients: Mechanism and treatment strategy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33436320.
- Also identified by DOI 10.1016/j.pcd.2021.01.002 and PMC identifier 7834268.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This review reported that coronavirus disease 2019 (COVID-19) infected patients with short time bed rest or quarantine and airway inflammation are at more risk of developing hyperglycemia and insulin resistance. This condition can induce oxidative stress, decrease immune system function, impair endothelial function, induce apoptosis, and reduce antioxidant in the lungs. We provide a possible mechanism in severe COVID-19 patients and recommend treatment strategy to reduce mortality rate and prevent adverse outcomes after intensive care unit (ICU).
Medical subject headings
- Blood Glucose
- COVID-19
- Disease Management
- Hyperglycemia
- Intensive Care Units